Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / ADR
-
Number of holders
-
722
-
Total 13F shares, excl. options
-
249,750,914
-
Shares change
-
-2,453,987
-
Total reported value, excl. options
-
$11,526,753,874
-
Value change
-
-$100,820,332
-
Put/Call ratio
-
199%
-
Number of buys
-
363
-
Number of sells
-
264
-
Price
-
$46.15
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2015
As of 31 Mar 2015 GLAXOSMITHKLINE PLC - ADR (GSK) had 722 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 249,750,914 shares of stock of the company.
Largest 10 holders included Dodge & Cox, FMR LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, ROYAL BANK OF CANADA, WELLS FARGO & COMPANY/MN, Fisher Asset Management, LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Allianz Asset Management AG, and Invesco Ltd..
This table shows 723 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.